Anavex Life Sciences
AVXL
#9426
Rank
HK$1.11 B
Marketcap
HK$12.01
Share price
2.68%
Change (1 day)
-82.10%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -HK$0.11 Billion

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -HK$0.32 Billion, an increase over its 2024 earnings that were of -HK$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.11 Billion-67.9%
2025 -HK$0.32 Billion-22.43%
2024 -HK$0.41 Billion14.77%
2023 -HK$0.36 Billion-17.49%
2022 -HK$0.43 Billion22.96%
2021 -HK$0.35 Billion35.36%
2020 -HK$0.26 Billion12.65%
2019 -HK$0.23 Billion29.09%
2018 -HK$0.18 Billion36.33%
2017 -HK$0.13 Billion17.11%
2016 -HK$0.12 Billion20.91%
2015 -HK$91.45 Million-6.29%
2014 -HK$97.59 Million337.28%
2013 -HK$22.32 Million
2008 -HK$41.27 Million106.01%
2007 -HK$20.04 Million8848.98%
2006 -HK$0.23 Million-79.99%
2005 -HK$1.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
HK$1.91 B-1,984.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
HK$50.26 M-149.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$48.99 Million-51.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$3 Billion 2,842.85%๐Ÿ‡บ๐Ÿ‡ธ USA